The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
iShares Global Healthcare ETF IXJ
Morningstar’s Analysis IXJ
Will IXJ outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 8.82 | 376.8 Mil | Healthcare |
UnitedHealth Group Inc | 6.81 | 290.8 Mil | Healthcare |
Novo Nordisk AS Class B | 4.73 | 201.8 Mil | Healthcare |
Johnson & Johnson | 4.68 | 199.7 Mil | Healthcare |
AbbVie Inc | 4.40 | 187.8 Mil | Healthcare |
Merck & Co Inc | 3.68 | 157.1 Mil | Healthcare |
AstraZeneca PLC | 3.08 | 131.4 Mil | Healthcare |
Thermo Fisher Scientific Inc | 2.96 | 126.5 Mil | Healthcare |
Novartis AG Registered Shares | 2.86 | 121.9 Mil | Healthcare |
Roche Holding AG | 2.79 | 119.1 Mil | Healthcare |